JOHN K BAKEWELL Insider Trading
Get free email notifications about insider trading for JOHN K BAKEWELL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN K BAKEWELL. JOHN K BAKEWELL is a Chief Financial Officer in EXACT SCIENCES CORP ($EXAS) and a Exec VP and CFO in WRIGHT MEDICAL GROUP INC ($WMGI) and a Exec. VP & CFO in WRIGHT MEDICAL GROUP INC ($WMGI) and a Exec. VP & CFO in WRIGHT MEDICAL GROUP INC ($WMGI) and a Exec. VP and CFO in WRIGHT MEDICAL GROUP INC ($WMGI) and a Director in Neuronetics, Inc. ($STIM) and a Director in ENTELLUS MEDICAL INC ($ENTL) and a Director in Xtant Medical Holdings, Inc. ($XTNT) and a Director in Corindus Vascular Robotics, Inc. ($CVRS) and a CFO and Treasurer in Lantheus Holdings, Inc. ($LNTH) and a Director in TREACE MEDICAL CONCEPTS, INC. ($TMCI) and a SVP, Research & Development in TREACE MEDICAL CONCEPTS, INC. ($TMCI).
Address: 5677 AIRLINE ROAD ARLINGTON 38002 TN
Companies in which JOHN K BAKEWELL is an Insider
Corindus Vascular Robotics, Inc.
Trading Symbol: CVRSIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of JOHN K BAKEWELL: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 19 2017
$CVRS Market Capitalization: $60.60M
$CVRS Previous Close: $0.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ENTELLUS MEDICAL INC
Trading Symbol: ENTLIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of JOHN K BAKEWELL: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 01 2018
$ENTL Market Capitalization: $316.35M
$ENTL Previous Close: $16.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EXACT SCIENCES CORP
Trading Symbol: EXASIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of JOHN K BAKEWELL: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 05 2016
$EXAS Market Capitalization: $2.00B
$EXAS Previous Close: $18.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Lantheus Holdings, Inc.
Trading Symbol: LNTHIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of JOHN K BAKEWELL: CFO and Treasurer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 04 2016
$LNTH Market Capitalization: $323.30M
$LNTH Previous Close: $9.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neuronetics, Inc.
Trading Symbol: STIMIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of JOHN K BAKEWELL: Director
Holdings: 42,291 shares
Latest Transaction: Aug 07 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TREACE MEDICAL CONCEPTS, INC.
Trading Symbol: TMCIIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of JOHN K BAKEWELL: SVP, Research & Development, Director
Holdings: 342,300 shares
Latest Transaction: Apr 29 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
WRIGHT MEDICAL GROUP INC
Trading Symbol: WMGIIndustry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
Position of JOHN K BAKEWELL: Exec. VP & CFO, Exec. VP & CFO, Exec. VP and CFO, Exec VP and CFO
Holdings: 8,043 shares
Current Value: $210,003
Latest Transaction: Dec 11 2009
$WMGI Market Capitalization: $2.69B
$WMGI Previous Close: $26.11
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Xtant Medical Holdings, Inc.
Trading Symbol: XTNTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN K BAKEWELL: Director
Holdings: 147,794 shares
Current Value: $66,507
Latest Transaction: Feb 07 2020
$XTNT Market Capitalization: $5.29M
$XTNT Previous Close: $0.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN K BAKEWELL
Sentiment: All, CVRS, ENTL, EXAS, LNTH, STIM, TMCI, WMGI, XTNT
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | BAKEWELL JOHN K | SVP, Research & Dev ... | Option Exercise | C | 0.00 | 342,300 | 0 | 0 | |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | BAKEWELL JOHN K | SVP, Research & Dev ... | Option Exercise | J | 0.00 | 7,925 | 0 | 342,300 | |
Apr 29 2021 | TMCI | TREACE MEDICAL CON ... | BAKEWELL JOHN K | SVP, Research & Dev ... | Buy | C | 0.00 | 342,300 | 0 | 342,300 | 0 to 342.3 K |
Apr 26 2021 | TMCI | TREACE MEDICAL CON ... | BAKEWELL JOHN K | Director | Option Exercise | A | 17.00 | 21,240 | 361,080 | 21,240 | |
Apr 26 2021 | TMCI | TREACE MEDICAL CON ... | BAKEWELL JOHN K | Director | Option Exercise | A | 17.00 | 21,240 | 361,080 | 21,240 | |
Aug 07 2020 | STIM | Neuronetics, Inc. | BAKEWELL JOHN K | Director | Grant | A | 0.00 | 12,291 | 0 | 42,291 | 30 K to 42.3 K (+40.97 %) |
May 28 2020 | STIM | Neuronetics, Inc. | BAKEWELL JOHN K | Director | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |